Why Is Hyperparathyroidism Underdiagnosed and Undertreated in Older Adults?

Alex Dombrowsky, Benjamin Borg, Rongbing Xie, James K. Kirklin, Herbert Chen, Courtney J. Balentine

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Introduction: Hyperparathyroidism significantly decreases quality of life, yet elderly patients are underdiagnosed and undertreated even though parathyroidectomy offers definitive cure with minimal morbidity. The purpose of this study is to determine why older patients with hyperparathyroidism are not appropriately diagnosed and referred for parathyroidectomy. Methods: We reviewed charts for a random sample of 25 patients aged 75 and older who had hyperparathyroidism and were referred for surgical evaluation, and 25 who were not referred. Two reviewers independently evaluated medical records to identify reasons for delayed diagnosis of hyperparathyroidism and reasons for nonreferral for parathyroidectomy. Results: The median age of our cohort was 84 (80-96) years, 90% were women, 60% were white, and median follow-up was 5.5 (1-17) years. In 58% of all patients, an elevated serum calcium was not acknowledged. Even when calcium and parathyroid hormone levels were both elevated, the diagnosis was missed in 28% of patients, and 16% with clear symptoms of hyperparathyroidism remained undiagnosed. For 42% of patients, a nonsurgeon informed them that surgery offered no benefit. Surgery was also rejected as a treatment for 36% of patients despite the development of new symptoms or rising calcium. Conclusions: Substantial gaps exist in processes for diagnosis and referral of patients with hyperparathyroidism that lead to underdiagnosis and undertreatment. To improve rates of diagnosis and treatment, strategies are needed to educate nonsurgeons and patients about the benefits of surgery and to modify care processes to more efficiently diagnose and refer patients.

Original languageEnglish (US)
JournalClinical Medicine Insights: Endocrinology and Diabetes
Volume11
DOIs
StatePublished - Dec 1 2018

Fingerprint

Hyperparathyroidism
Parathyroidectomy
Calcium
Delayed Diagnosis
Parathyroid Hormone
Medical Records
Referral and Consultation
Quality of Life
Morbidity

Keywords

  • elderly
  • Hyperparathyroidism
  • parathyroidectomy
  • underdiagnosis

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Why Is Hyperparathyroidism Underdiagnosed and Undertreated in Older Adults? / Dombrowsky, Alex; Borg, Benjamin; Xie, Rongbing; Kirklin, James K.; Chen, Herbert; Balentine, Courtney J.

In: Clinical Medicine Insights: Endocrinology and Diabetes, Vol. 11, 01.12.2018.

Research output: Contribution to journalArticle

Dombrowsky, Alex ; Borg, Benjamin ; Xie, Rongbing ; Kirklin, James K. ; Chen, Herbert ; Balentine, Courtney J. / Why Is Hyperparathyroidism Underdiagnosed and Undertreated in Older Adults?. In: Clinical Medicine Insights: Endocrinology and Diabetes. 2018 ; Vol. 11.
@article{949e459a3da44c97a1b4e93366ebd8ee,
title = "Why Is Hyperparathyroidism Underdiagnosed and Undertreated in Older Adults?",
abstract = "Introduction: Hyperparathyroidism significantly decreases quality of life, yet elderly patients are underdiagnosed and undertreated even though parathyroidectomy offers definitive cure with minimal morbidity. The purpose of this study is to determine why older patients with hyperparathyroidism are not appropriately diagnosed and referred for parathyroidectomy. Methods: We reviewed charts for a random sample of 25 patients aged 75 and older who had hyperparathyroidism and were referred for surgical evaluation, and 25 who were not referred. Two reviewers independently evaluated medical records to identify reasons for delayed diagnosis of hyperparathyroidism and reasons for nonreferral for parathyroidectomy. Results: The median age of our cohort was 84 (80-96) years, 90{\%} were women, 60{\%} were white, and median follow-up was 5.5 (1-17) years. In 58{\%} of all patients, an elevated serum calcium was not acknowledged. Even when calcium and parathyroid hormone levels were both elevated, the diagnosis was missed in 28{\%} of patients, and 16{\%} with clear symptoms of hyperparathyroidism remained undiagnosed. For 42{\%} of patients, a nonsurgeon informed them that surgery offered no benefit. Surgery was also rejected as a treatment for 36{\%} of patients despite the development of new symptoms or rising calcium. Conclusions: Substantial gaps exist in processes for diagnosis and referral of patients with hyperparathyroidism that lead to underdiagnosis and undertreatment. To improve rates of diagnosis and treatment, strategies are needed to educate nonsurgeons and patients about the benefits of surgery and to modify care processes to more efficiently diagnose and refer patients.",
keywords = "elderly, Hyperparathyroidism, parathyroidectomy, underdiagnosis",
author = "Alex Dombrowsky and Benjamin Borg and Rongbing Xie and Kirklin, {James K.} and Herbert Chen and Balentine, {Courtney J.}",
year = "2018",
month = "12",
day = "1",
doi = "10.1177/1179551418815916",
language = "English (US)",
volume = "11",
journal = "Clinical Medicine Insights: Endocrinology and Diabetes",
issn = "1179-5514",
publisher = "Libertas Academica Ltd.",

}

TY - JOUR

T1 - Why Is Hyperparathyroidism Underdiagnosed and Undertreated in Older Adults?

AU - Dombrowsky, Alex

AU - Borg, Benjamin

AU - Xie, Rongbing

AU - Kirklin, James K.

AU - Chen, Herbert

AU - Balentine, Courtney J.

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Introduction: Hyperparathyroidism significantly decreases quality of life, yet elderly patients are underdiagnosed and undertreated even though parathyroidectomy offers definitive cure with minimal morbidity. The purpose of this study is to determine why older patients with hyperparathyroidism are not appropriately diagnosed and referred for parathyroidectomy. Methods: We reviewed charts for a random sample of 25 patients aged 75 and older who had hyperparathyroidism and were referred for surgical evaluation, and 25 who were not referred. Two reviewers independently evaluated medical records to identify reasons for delayed diagnosis of hyperparathyroidism and reasons for nonreferral for parathyroidectomy. Results: The median age of our cohort was 84 (80-96) years, 90% were women, 60% were white, and median follow-up was 5.5 (1-17) years. In 58% of all patients, an elevated serum calcium was not acknowledged. Even when calcium and parathyroid hormone levels were both elevated, the diagnosis was missed in 28% of patients, and 16% with clear symptoms of hyperparathyroidism remained undiagnosed. For 42% of patients, a nonsurgeon informed them that surgery offered no benefit. Surgery was also rejected as a treatment for 36% of patients despite the development of new symptoms or rising calcium. Conclusions: Substantial gaps exist in processes for diagnosis and referral of patients with hyperparathyroidism that lead to underdiagnosis and undertreatment. To improve rates of diagnosis and treatment, strategies are needed to educate nonsurgeons and patients about the benefits of surgery and to modify care processes to more efficiently diagnose and refer patients.

AB - Introduction: Hyperparathyroidism significantly decreases quality of life, yet elderly patients are underdiagnosed and undertreated even though parathyroidectomy offers definitive cure with minimal morbidity. The purpose of this study is to determine why older patients with hyperparathyroidism are not appropriately diagnosed and referred for parathyroidectomy. Methods: We reviewed charts for a random sample of 25 patients aged 75 and older who had hyperparathyroidism and were referred for surgical evaluation, and 25 who were not referred. Two reviewers independently evaluated medical records to identify reasons for delayed diagnosis of hyperparathyroidism and reasons for nonreferral for parathyroidectomy. Results: The median age of our cohort was 84 (80-96) years, 90% were women, 60% were white, and median follow-up was 5.5 (1-17) years. In 58% of all patients, an elevated serum calcium was not acknowledged. Even when calcium and parathyroid hormone levels were both elevated, the diagnosis was missed in 28% of patients, and 16% with clear symptoms of hyperparathyroidism remained undiagnosed. For 42% of patients, a nonsurgeon informed them that surgery offered no benefit. Surgery was also rejected as a treatment for 36% of patients despite the development of new symptoms or rising calcium. Conclusions: Substantial gaps exist in processes for diagnosis and referral of patients with hyperparathyroidism that lead to underdiagnosis and undertreatment. To improve rates of diagnosis and treatment, strategies are needed to educate nonsurgeons and patients about the benefits of surgery and to modify care processes to more efficiently diagnose and refer patients.

KW - elderly

KW - Hyperparathyroidism

KW - parathyroidectomy

KW - underdiagnosis

UR - http://www.scopus.com/inward/record.url?scp=85058627283&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058627283&partnerID=8YFLogxK

U2 - 10.1177/1179551418815916

DO - 10.1177/1179551418815916

M3 - Article

C2 - 30559598

AN - SCOPUS:85058627283

VL - 11

JO - Clinical Medicine Insights: Endocrinology and Diabetes

JF - Clinical Medicine Insights: Endocrinology and Diabetes

SN - 1179-5514

ER -